Zura Bio SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 27, 2026, 7:40 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedZura Bio Reports Q3 2026 Net Loss of $25.8 million, $0.20 per Share, With $187.7 million Cash Through 2028
10-QOct. 27, 2026, 7:38 a.m. ETView on SEC.gov
8-KAug. 17, 2026, 7 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KAug. 11, 2026, 7:35 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
10-QAug. 11, 2026, 7:34 a.m. ETView on SEC.gov